Neutrophil and eosinophil granulocytes as key players in a mouse model of chemical-induced asthma

Toxicological Sciences

Volumn 131, Issue 2, 2013, Pages 406-418

  De Vooght, Vanessa ^a   Smulders, Stijn ^a   Haenen, Steven ^a   Belmans, Jochen ^a   Opdenakker, Ghislain ^b   Verbeken, Erik ^c   Nemery, Benoit ^a   Hoet, Peter H M ^a   Vanoirbeek, Jeroen A J ^a  

^a Environmental and Insurance Medicine   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c Morphology and Molecular Pathology Section   (Belgium)

Author keywords

1A8; AGR1; Chemical induced asthma; Cyclophosphamide; Neutrophil depletion; TDI

Indexed keywords

ACETONE; CYCLOPHOSPHAMIDE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 14; INTERLEUKIN 2; INTERLEUKIN 4; METHACHOLINE; MONOCLONAL ANTIBODY; OLIVE OIL; TOLUENE DIISOCYANATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BLOOD LEVEL; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHIL; GRANULOCYTE; HISTOPATHOLOGY; INFLAMMATION; LEUKOCYTE; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; OROPHARYNX;

ANIMALS; ASTHMA; BODY WEIGHT; CYCLOPHOSPHAMIDE; EOSINOPHILS; LYMPH NODES; MALE; MICE; MICE, INBRED BALB C; NEUTROPHILS; TOLUENE 2,4-DIISOCYANATE;

EID: 84873803202     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs308     Document Type: Article

References (41)

1. Abbitt, K. B., Cotter, M. J., Ridger, V. C., Crossman, D. C., Hellewell, P. G., and Norman, K. E. (2009). Antibody ligation of murine Ly-6G induces neutropenia, blood flow cessation, and death via complement-dependent and independent mechanisms. J. Leukoc. Biol. 85, 55-63.
2. Borregaard, N. (2010). Neutrophils, from marrow to microbes. Immunity 33, 657-670.
3. Cundall, M., Sun, Y., Miranda, C., Trudeau, J. B., Barnes, S., and Wenzel, S. E. (2003). Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J. Allergy Clin. Immunol. 112, 1064-1071.
4. Daley, J. M., Thomay, A. A., Connolly, M. D., Reichner, J. S., and Albina, J. E. (2008). Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83, 64-70.
5. De Vooght, V., Vanoirbeek, J. A., Haenen, S., Verbeken, E., Nemery, B., and Hoet, P. H. (2009). Oropharyngeal aspiration: An alternative route for challenging in a mouse model of chemical-induced asthma. Toxicology 259, 84-89.
6. De Vooght, V., Cruz, M. J., Haenen, S., Wijnhoven, K., Muñoz, X., Hoet, P. H., Morell, F., Nemery, B., and Vanoirbeek, J. A. (2010a). Ammonium persulfate can initiate an asthmatic response in mice. Thorax 65, 252-257.
7. De Vooght, V., Vanoirbeek, J. A., Luyts, K., Haenen, S., Nemery, B., and Hoet, P. H. (2010b). Choice of mouse strain influences the outcome in a mouse model of chemical-induced asthma. PLoS ONE 5, e12581.
8. Emadi, A., Jones, R. J., and Brodsky, R. A. (2009). Cyclophosphamide and cancer: Golden anniversary. Nat. Rev. Clin. Oncol. 6, 638-647.
9. Gordeuk, V. R., Prithviraj, P., Dolinar, T., and Brittenham, G. M. (1988). Interleukin 1 administration in mice produces hypoferremia despite neutropenia. J. Clin. Invest. 82, 1934-1938.
10. Grunig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998). Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282, 2261-2263.
11. Hamelmann, E., Oshiba, A., Paluh, J., Bradley, K., Loader, J., Potter, T. A., Larsen, G. L., and Gelfand, E. W. (1996). Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a marine model of airway sensitization. J. Exp. Med. 183, 1719-1729.
12. Lemanske, R. F. Jr, and Busse, W. W. (2010). Asthma: Clinical expression and molecular mechanisms. J. Allergy Clin. Immunol. 125(Suppl. 2), S95-102.
13. Lemiere, C., Romeo, P., Chaboillez, S., Tremblay, C., and Malo, J. L. (2002). Airway inflammation and functional changes after exposure to different concentrations of isocyanates. J. Allergy Clin. Immunol. 110, 641-646.
14. Li, S., Starckx, S., Martens, E., Dillen, C., Lamerant-Fayel, N., Berghmans, N., Gouwy, M., van Pel, M., Heremans, H., Kieda, C., et al. (2010). Myeloid cells are tunable by a polyanionic polysaccharide derivative and co-determine host rescue from lethal virus infection. J. Leukoc. Biol. 88, 1017-1029.
15. Matheson, J. M., Johnson, V. J., and Luster, M. I. (2005). Immune mediators in a murine model for occupational asthma: Studies with toluene diisocyanate. Toxicol. Sci. 84, 99-109.
16. Matheson, J. M., Lange, R. W., Lemus, R., Karol, M. H., and Luster, M. I. (2001). Importance of inflammatory and immune components in a mouse model of airway reactivity to toluene diisocyanate (TDI). Clin. Exp. Allergy 31, 1067-1076.
17. Mauti, L. A., Le Bitoux, M. A., Baumer, K., Stehle, J. C., Golshayan, D., Provero, P., and Stamenkovic, I. (2011). Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation. J. Clin. Invest. 121, 2794-2807.
18. Mizutani, N., Goshima, H., Nabe, T., and Yoshino, S. (2012). Complement C3a-induced IL-17 plays a critical role in an IgE-mediated late-phase asthmatic response and airway hyperresponsiveness via neutrophilic inflammation in mice. J. Immunol. 188, 5694-5705.
19. Monteseirin, J. (2009). Neutrophils and asthma. J. Investig. Allergol. Clin. Immunol. 19, 340-354.
20. Opdenakker, G., Fibbe, W. E., and Van Damme, J. (1998). The molecular basis of leukocytosis. Immunol. Today 19, 182-189.
21. Ordonez, C. L., Shaughnessy, T. E., Matthay, M. A., and Fahy, J. V. (2000). Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance. Am. J. Respir. Crit. Care Med. 161(4 Pt 1), 1185-1190.
22. Park, H., Jung, K., Kim, H., Nahm, D., and Kang, K. (1999). Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin. Exp. Allergy 29, 1395-1401.
23. Park, J. W., Taube, C., Joetham, A., Takeda, K., Kodama, T., Dakhama, A., McConville, G., Allen, C. B., Sfyroera, G., Shultz, L. D., et al. (2004). Complement activation is critical to airway hyperresponsiveness after acute ozone exposure. Am. J. Respir. Crit. Care Med. 169, 726-732.
24. Profita, M., Sala, A., Bonanno, A., Riccobono, L., Siena, L., Melis, M. R., Di Giorgi, R., Mirabella, F., Gjomarkaj, M., Bonsignore, G., et al. (2003). Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia. J. Allergy Clin. Immunol. 112, 709-716.
25. Sanz, M. J., and Kubes, P. (2012). Neutrophil-active chemokines in in vivo imaging of neutrophil trafficking. Eur. J. Immunol. 42, 278-283.
26. Saoulidis, S., Simitsopoulou, M., Dalakiouridou, M., Walsh, T. J., Wheat, L. J., Papaioannidou, P., and Roilides, E. (2011). Antifungal activity of posaconazole and granulocyte colony-stimulating factor in the treatment of disseminated zygomycosis (mucormycosis) in a neutropaenic murine model. Mycoses 54, e486-e492.
27. Savov, J. D., Gavett, S. H., Brass, D. M., Costa, D. L., and Schwartz, D. A. (2002). Neutrophils play a critical role in development of LPS-induced airway disease. Am. J. Physiol. Lung Cell Mol. Physiol. 283, L952-L962.
28. Taha, R. A., Laberge, S., Hamid, Q., and Olivenstein, R. (2001). Increased expression of the chemoattractant cytokines eotaxin, monocyte chemotactic protein-4, and interleukin-16 in induced sputum in asthmatic patients. Chest 120, 595-601.
29. Tarkowski, M., Vanoirbeek, J. A., Vanhooren, H. M., De Vooght, V., Mercier, C. M., Ceuppens, J., Nemery, B., and Hoet, P. H. (2007). Immunological determinants of ventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate. Am. J. Physiol. Lung Cell Mol. Physiol. 292, L207-L214.
30. Tate, M. D., Deng, Y. M., Jones, J. E., Anderson, G. P., Brooks, A. G., and Reading, P. C. (2009). Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J. Immunol. 183, 7441-7450.
31. Vanoirbeek, J. A., De Vooght, V., Vanhooren, H. M., Nawrot, T. S., Nemery, B., and Hoet, P. H. (2008). How long do the systemic and ventilatory responses to toluene diisocyanate persist in dermally sensitized mice? J. Allergy Clin. Immunol. 121, 456-463.e5.
32. Vanoirbeek, J. A., Rinaldi, M., De Vooght, V., Haenen, S., Bobic, S., Gayan-Ramirez, G., Hoet, P. H., Verbeken, E., Decramer, M., Nemery, B., et al. (2010). Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am. J. Respir. Cell Mol. Biol. 42, 96-104.
33. Vanoirbeek, J. A., Tarkowski, M., Ceuppens, J. L., Verbeken, E. K., Nemery, B., and Hoet, P. H. (2004). Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice. Toxicol. Sci. 80, 310-321.
34. Vanoirbeek, J. A., Tarkowski, M., Vanhooren, H. M., De Vooght, V., Nemery, B., and Hoet, P. H. (2006). Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. J. Allergy Clin. Immunol. 117, 1090-1097.
35. Venkayya, R., Lam, M., Willkom, M., Grünig, G., Corry, D. B., and Erle, D. J. (2002). The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am. J. Respir. Cell Mol. Biol. 26, 202-208.
36. Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., and Donaldson, D. D. (1998). Interleukin-13: Central mediator of allergic asthma. Science 282, 2258-2261.
37. Wojtasiak, M., Pickett, D. L., Tate, M. D., Londrigan, S. L., Bedoui, S., Brooks, A. G., and Reading, P. C. (2010). Depletion of Gr-1+, but not Ly6G+, immune cells exacerbates virus replication and disease in an intranasal model of herpes simplex virus type 1 infection. J. Gen. Virol. 91(Pt 9), 2158-2166.
38. Wynn, T. A. (2003). IL-13 effector functions. Annu. Rev. Immunol. 21, 425-456.
39. Xu, P., Qu, J. M., Xu, J. F., Zhang, J., Jiang, H. N., and Zhang, H. J. (2009). NAC is associated with additional alleviation of lung injury induced by invasive pulmonary aspergillosis in a neutropenic model. Acta Pharmacol. Sin. 30, 980-986.
40. Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., and Elias, J. A. (1999). Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103, 779-788.
41. Zuluaga, A. F., Salazar, B. E., Rodriguez, C. A., Zapata, A. X., Agudelo, M., and Vesga, O. (2006). Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: Characterization and applicability to diverse experimental models of infectious diseases. BMC Infect. Dis. 6, 55.